Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 106Leukemia 98Lymphoma 79Burkitt Lymphoma 52Leukemia, Myeloid, Acute 51Myelodysplastic Syndromes 41Lymphoma, Non-Hodgkin 41Lymphoma, Large B-Cell, Diffuse 35Lymphoma, Mantle-Cell 33Leukemia, Lymphocytic, Chronic, B-Cell 32Leukemia, Myeloid, Accelerated Phase 30Hodgkin Disease 29Lymphoma, Follicular 28Blast Crisis 27Graft vs Host Disease 26Congenital Abnormalities 26Myeloproliferative Disorders 25Leukemia, Myeloid, Chronic-Phase 25Multiple Myeloma 24Breast Neoplasms 23Lymphoma, B-Cell, Marginal Zone 22Leukemia, Myelomonocytic, Chronic 22Lymphoma, Large-Cell, Immunoblastic 21Primary Myelofibrosis 16Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 16Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 16Recurrence 15Neoplasms, Plasma Cell 15Dendritic Cell Sarcoma, Interdigitating 15Anemia, Refractory, with Excess of Blasts 15

Interventions

efgartigimod alfa 2Rituximab 2Hizentra 2zilucoplan 1thymoglobulin 1rozanolixizumab 1rhoA GTP-Binding Protein 1prednylidene 1iscalimab 1inebilizumab 1gamma-Globulins 1eculizumab 1deltacortene 1carmustine, poliferprosan 20 drug combination 1apraclonidine 1Sternotomy 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1Melphalan 1Immunoglobulins, Intravenous 1HBM9161 1Fluid Therapy 1Etoposide 1Cytarabine 1Carmustine 1CK-2017357 1Bortezomib 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Myasthenia Gravis × Methotrexate × Clear all
NCT00814138 2016-05-26

Efficacy of Methotrexate in Myasthenia Gravis

University of Kansas Medical Center

Phase 2 Completed
50 enrolled 15 charts

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡